Učitavanje...
Remarkable response of a patient with secondary glioblastoma to a histone deacetylase inhibitor
Secondary glioblastoma is a rare brain tumor characterized by a mutation in isocitrate dehydrogenase, which is reported to lead to epigenetic modification. Patients with secondary glioblastoma experience poor survival and quality-of-life outcomes due to the disease’s aggressiveness and a lack of tar...
Spremljeno u:
| Izdano u: | Oxf Med Case Reports |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104214/ https://ncbi.nlm.nih.gov/pubmed/32257248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa006 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|